Press Release
The AGEs Society publishes the disease consultation reference book, 'Glycotoxin Shock'
2024.09.09 15:53- 작성자 관리자
- 조회 27
[DailyPharm Reporter: Hye-Kyoung Kang] MetaCen Therapeutics and the AGEs Society (led by CEO Myoung-Gyu Park) have published a disease consultation reference book titled 'Glycotoxin Shock.'
"Glycotoxin Shock," co-authored by CEO Myoung-Gyu Park and academic pharmacist Ah-Reum Kim, is based on the latest research, drawing attention to the threat glycotoxins pose to modern health. The book identifies glycotoxins as a contributing factor to serious diseases such as cancer and dementia, while emphasizing the need for changes in modern dietary habits.
The AGEs Society stated, "This book explains the definition of glycotoxins, their impact on modern health, and the diseases they can cause. It also provides readers with practical prevention and solutions that can be applied in everyday life, serving as a guide for systematically managing health issues."
They further added, "We expect the book to become a must-read for pharmacists operating disease consultation pharmacies, helping them better manage modern health concerns."
Source: [DailyPharm](http://www.dailypharm.com)
"Glycotoxin Shock," co-authored by CEO Myoung-Gyu Park and academic pharmacist Ah-Reum Kim, is based on the latest research, drawing attention to the threat glycotoxins pose to modern health. The book identifies glycotoxins as a contributing factor to serious diseases such as cancer and dementia, while emphasizing the need for changes in modern dietary habits.
The AGEs Society stated, "This book explains the definition of glycotoxins, their impact on modern health, and the diseases they can cause. It also provides readers with practical prevention and solutions that can be applied in everyday life, serving as a guide for systematically managing health issues."
They further added, "We expect the book to become a must-read for pharmacists operating disease consultation pharmacies, helping them better manage modern health concerns."
Source: [DailyPharm](http://www.dailypharm.com)